Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Other financing activities (2021 - 2025)

P3 Health Partners' Other financing activities history spans 3 years, with the latest figure at $12000.0 for Q4 2025.

  • For Q4 2025, Other financing activities rose 300.0% year-over-year to $12000.0; the TTM value through Dec 2025 reached $186000.0, up 80.58%, while the annual FY2025 figure was $186000.0, 80.58% up from the prior year.
  • Other financing activities reached $12000.0 in Q4 2025 per PIIIW's latest filing, up from -$7000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $6.4 million in Q2 2021 to a low of -$6.3 million in Q3 2021.
  • Average Other financing activities over 3 years is $66400.0, with a median of $27000.0 recorded in 2025.
  • The largest YoY upside for Other financing activities was 300.0% in 2025 against a maximum downside of 107.0% in 2025.
  • A 3-year view of Other financing activities shows it stood at $7972.0 in 2021, then plummeted by 62.37% to $3000.0 in 2024, then soared by 300.0% to $12000.0 in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Other financing activities are $12000.0 (Q4 2025), -$7000.0 (Q3 2025), and $42000.0 (Q2 2025).